Compare PRAX & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | TKR |
|---|---|---|
| Founded | 2015 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 9.2B |
| IPO Year | 2020 | 1994 |
| Metric | PRAX | TKR |
|---|---|---|
| Price | $250.33 | $137.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $572.13 | $118.29 |
| AVG Volume (30 Days) | 439.6K | ★ 1.0M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $80,100,000.00 |
| Revenue This Year | N/A | $4.57 |
| Revenue Next Year | $7,758.26 | $3.97 |
| P/E Ratio | ★ N/A | $96.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.25 | $70.07 |
| 52 Week High | $366.52 | $136.59 |
| Indicator | PRAX | TKR |
|---|---|---|
| Relative Strength Index (RSI) | 30.44 | 73.37 |
| Support Level | $157.29 | $105.06 |
| Resistance Level | $342.62 | N/A |
| Average True Range (ATR) | 21.30 | 4.24 |
| MACD | -10.67 | 0.82 |
| Stochastic Oscillator | 4.85 | 87.87 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The various products offered by the company include ball bearings, plain bearings, tapered roller bearings, housed bearings, linear guides, telescopic rails, lubrication systems, agricultural conveyor chains, couplings, brakes, seals, etc. These products are offered through brands like Timken, GGB, Philadelphia Gear, Cone Drive, CGI, and Rollon, among others. The company has two reportable segments: Engineered Bearings, which generates the maximum revenue, and Industrial Motion. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Africa (EMEA), Asia-Pacific, and the other regions of the Americas.